Autres langues Kyung Nam Pharm Co.,Ltd.

Actions

A053950

KR7053950002

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 21/06/2024			Varia. 5j.	Varia. 1 janv.
1 047 ^KRW	-0,95 %		0,00 %	-37,75 %

2023

Kyung Nam Pharm Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2023

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding	22/09/23
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	18/09/23
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding	10/08/23
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	17/07/23
Kyung Nam Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Kyung Nam Pharm Co.,Ltd. agreed to acquire 9.94% stake in ILYA Co., Ltd from Kang, Jae Woo and Han, Seung Ja for KRW 7 billion.	15/03/23
Enterpartners Co., LTD announced that it expects to receive KRW 26.599899939 billion in funding from Kyung Nam Pharm Co.,Ltd.	14/11/22
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.	24/12/21
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 8 billion in funding from Metaplex Co., Ltd., and other investors	10/12/21
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 8 billion in funding from Metaplex Co., Ltd., and other investors	30/11/21
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	20/07/21
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	12/07/21
Kyung Nam Pharm Co.,Ltd., Virtualtek Corp and Ventage Partners Co., Ltd. agreed to acquire 9.32% stake in Livefinancial Co.,Ltd. for KRW 5.8 billion.	16/07/20
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.	01/07/20
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors	10/06/20
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors	04/06/20
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.	30/03/20
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.	23/05/19
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 6.49999411 billion in funding from BioGenetics CO.,LTD.	21/05/19
BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.	13/05/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kyung Nam Pharm Co.,Ltd.

Actions

A053950

KR7053950002

Autres langues

Filtres